Furthermore, loss of CAMK2N1 expression contributes to prostate cancer growth and survival independent of androgen signaling and re-introduction of CAMK2N1 sensitizes castration-resistant prostate cancer cells to anti-androgen therapy. Here, CAMK2N1 is linked to Familial prostate cancer.